Literature DB >> 29953422

Superior Hypertension Management in Pediatric Kidney Transplant Patients After Native Nephrectomy.

Aleah L Brubaker1, Daniel J Stoltz1, Abanti Chaudhuri2, Lynn Maestretti2, Paul C Grimm2, Waldo Concepcion1, Amy E Gallo1.   

Abstract

BACKGROUND: Native nephrectomy in pediatric kidney transplant recipients is performed for multiple indications. Posttransplant hypertension requiring medical management is common, and the effect of native nephrectomy on posttransplant hypertension is poorly studied. Our aim is to evaluate the impact of native nephrectomy on posttransplant hypertension.
METHODS: One hundred thirty-six consecutive pediatric kidney transplant recipients from 2007 to 2012 were studied at a single institution and divided into 2 groups: no nephrectomy and native nephrectomy (unilateral and bilateral nephrectomy). Antihypertensive medication use was evaluated before nephrectomy/transplant, at discharge from transplant and at 1, 3, and 5 years posttransplant.
RESULTS: In a bivariate analysis, nephrectomy was associated with a significant reduction in the percentage of patients requiring antihypertensive medication at the time of discharge (27.3%) and 1 year posttransplant (10.7%) as compared with patients without nephrectomy (71.7%, and 50%, respectively, P < 0.05). This trend toward reduction in antihypertensive medication in the nephrectomy group as compared with the no nephrectomy group persisted at 3 (18.6% versus 43.2%) and 5 years (19.7% versus 37.5%) posttransplant. Multivariable logistic regression demonstrated that patients without native nephrectomy had higher odds of requiring antihypertensive medication at the time of discharge (3.3) and 1 year (5.2) as compared with patients who underwent native nephrectomy (P = 0.036 and P = 0.013, respectively).
CONCLUSIONS: Native nephrectomy reduces the odds of needing antihypertensive medication after transplant. The impact of native nephrectomy is crucial to the comprehensive management of pediatric transplant recipients where medication compliance is challenging and lifelong hypertension is known to negatively impact cardiovascular health.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29953422      PMCID: PMC7228635          DOI: 10.1097/TP.0000000000002093

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  22 in total

Review 1.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

2.  Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients.

Authors:  Jose Jayme G De Lima; Marcelo Luis C Vieira; Luis Fernando Viviani; Caio Jorge Medeiros; Luis Estevan Ianhez; Liliane Kopel; Jose L de Andrade; Eduardo M Krieger; Silvia G Lage
Journal:  Nephrol Dial Transplant       Date:  2002-04       Impact factor: 5.992

3.  Long-term cardiovascular effects of pre-transplant native kidney nephrectomy in children.

Authors:  Marco Cavallini; Giacomo Di Zazzo; Ugo Giordano; Giacomo Pongiglione; Luca Dello Strologo; Nicola Capozza; Francesco Emma; Maria Chiara Matteucci
Journal:  Pediatr Nephrol       Date:  2010-09-25       Impact factor: 3.714

4.  Renal transplant outcomes in adolescents: a report of the North American Pediatric Renal Transplant Cooperative Study.

Authors:  Jodi M Smith; P L M Ho; Ruth A McDonald
Journal:  Pediatr Transplant       Date:  2002-12

5.  Native nephrectomy in pediatric transplantation--less is more!

Authors:  Nia Fraser; P C Lyon; A R Williams; M T Christian; M U Shenoy
Journal:  J Pediatr Urol       Date:  2012-01-09       Impact factor: 1.830

6.  Laparoscopic bilateral nephrectomy for renin-mediated hypertension.

Authors:  G T Bales; S K Fellner; G W Chodak; D B Rukstalis
Journal:  Urology       Date:  1994-06       Impact factor: 2.649

7.  Risk factors for cardiovascular disease in children and young adults after renal transplantation.

Authors:  Rachel Becker-Cohen; Amiram Nir; Choni Rinat; Sofia Feinstein; Nurit Algur; Benjamin Farber; Yaacov Frishberg
Journal:  Clin J Am Soc Nephrol       Date:  2006-09-20       Impact factor: 8.237

8.  Longitudinal stability of specific barriers to medication adherence.

Authors:  Jennifer L Lee; Cyd Eaton; Ana M Gutiérrez-Colina; Katie Devine; Laura E Simons; Laura Mee; Ronald L Blount
Journal:  J Pediatr Psychol       Date:  2014-05-13

9.  Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporin. Leuven Collaborative Group for Transplantation.

Authors:  Y Vanrenterghem; M Waer; M R Christiaens; P Michielsen
Journal:  Transpl Int       Date:  1992       Impact factor: 3.782

10.  Native nephrectomy prior to pediatric kidney transplantation: biological and clinical aspects.

Authors:  Fatemeh Ghane Sharbaf; Martin Bitzan; Konrad M Szymanski; Lorraine E Bell; Indra Gupta; Jean Tchervenkov; John-Paul Capolicchio
Journal:  Pediatr Nephrol       Date:  2012-02-26       Impact factor: 3.714

View more
  3 in total

1.  Native nephrectomy in the management of hypertension in children with kidney disease: a tool to improve blood pressure control.

Authors:  Roma Subhash Varik; Arash Taghizadeh; Massimo Garriboli; Kalpana Patil; Anu Paul; Joanna Clothier; Manish D Sinha; Pankaj Mishra
Journal:  Pediatr Surg Int       Date:  2021-03-08       Impact factor: 1.827

2.  Contributions of afferent and sympathetic renal nerves to cystogenesis and arterial pressure regulation in a preclinical model of autosomal recessive polycystic kidney disease.

Authors:  Madeline M Gauthier; Melissa R Dennis; Mark N Morales; Heddwen L Brooks; Christopher T Banek
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-25

Review 3.  Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden.

Authors:  Francesco Reggiani; Gabriella Moroni; Claudio Ponticelli
Journal:  J Pers Med       Date:  2022-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.